The Proteolytic Activity of Separase in BCR-ABL-Positive Cells Is Increased by Imatinib
Table 2
Percent changes (Δ-values) in transcript levels, protein levels and proteolytic activity of Separase after IM treatment when compared to the corresponding untreated cells.1, 2